Hodgkin lymphoma mortality statistics

Deaths

Deaths from Hodgkin lymphoma, 2017-2019, UK.

 

Percentage of all deaths

Percentage Hodgkin lymphoma contributes to total cancer deaths, 2017-2019 UK

 

Age

Peak mortality rate for Hodgkin lymphoma, 2017-2019, UK

Trend over time

Change in hodgkin lymphoma mortality rates since the early 1970s, UK

Hodgkin lymphoma is not among the 20 most common causes of cancer death in the UK, accounting for less than 1% of all cancer deaths (2017-2019).[1-4]

In females in the UK, Hodgkin lymphoma is not among the 20 most common causes of cancer death (less than 1% of all female cancer deaths). In males in the UK, it is not among the 20 most common causes of cancer death (less than 1% of all male cancer deaths).

43% of Hodgkin lymphoma deaths in the UK are in females, and 57% are in males (2017-2019).

Hodgkin lymphoma mortality rates (European age-standardised Open a glossary item (AS) rates) in the UK are significantly lower in females than in males (2017-2019).

Hodgkin lymphoma mortality rates (European age-standardised Open a glossary item (AS) rates) for persons are similar to the UK average in all the UK constituent countries.

For Hodgkin lymphoma, mortality and incidence rates do not vary between the UK constituent nations.

Hodgkin Lymphoma (C81), Annual Average Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Persons Population, UK, 2017-2019

  England Scotland Wales Northern Ireland UK
Female Deaths 107 15 7 3 132
Crude Rate 0.4 0.5 0.5 0.3 0.4
AS Rate 0.4 0.5 0.4 0.3 0.4
AS Rate - 95% LCL 0.3 0.3 0.2 0.1 0.3
AS Rate - 95% UCL 0.4 0.6 0.6 0.5 0.4
Male Deaths 141 18 11 8 178
Crude Rate 0.5 0.7 0.7 0.9 0.5
AS Rate 0.6 0.8 0.7 1.1 0.6
AS Rate - 95% LCL 0.5 0.6 0.5 0.7 0.6
AS Rate - 95% UCL 0.6 1.0 1.0 1.6 0.7
Persons Deaths 248 33 18 11 311
Crude Rate 0.4 0.6 0.6 0.6 0.5
AS Rate 0.5 0.6 0.6 0.7 0.5
AS Rate - 95% LCL 0.4 0.5 0.4 0.5 0.5
AS Rate - 95% UCL 0.5 0.7 0.7 0.9 0.5

95% LCL and 95% UCL are the 95% lower and upper confidence limits around the AS Rate Open a glossary item

See also

Hodgkin lymphoma incidence statistics by sex and UK region

Hodgkin lymphoma survival statistics

Cancer mortality statistics for common cancers

Non-Hodgkin lymphoma mortality statistics by sex and UK region

References

  1. England and Wales data were accessed from Nomis mortality statistics by underlying cause, sex and age, November 2021: Nomis mortality statistics by underlying cause, sex and age.
  2. Scotland data were provided by ISD Scotland on request, November 2021. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp(link is external).
  3. Northern Ireland data were provided by the Northern Ireland Cancer Registry on request, February 2022. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.
  4. Population data were published by the Office for National statistics, accessed July 2020. The data can be found here: Population estimates for the UK, England and Wales, Scotland and Northern Ireland, provisional: mid-2019.

About this data

Data is for UK, 2017-2019, C81.

Last reviewed:

Hodgkin lymphoma mortality is strongly related to age, with the highest mortality rates being in older people. In the UK in 2017-2019, on average each year more than half of deaths (52%) were in people aged 75 and over.[1-4] This is a lower proportion of deaths in older age groups compared with most cancers.

Age-specific mortality rates remain stable from around age 20-24, rise steadily from around age 40-44 and more steeply from around age 60-64, with a drop for the 90+ age group. The highest rates are in the 85 to 89 age group for both females and males. Mortality rates are similar between females and males in most age groups.

Hodgkin Lymphoma (C81), Average Number of Deaths per Year and Age-Specific Mortality Rates per 100,000 Persons Population, UK, 2017-2019

See also

Hodgkin lymphoma incidence statistics by age

Hodgkin lymphoma survival statistics by age

Non-Hodgkin lymphoma mortality statistics by age

Cancer mortality statistics by age for all cancers

References

  1. England and Wales data were accessed from Nomis mortality statistics by underlying cause, sex and age, November 2021: Nomis mortality statistics by underlying cause, sex and age.
  2. Scotland data were provided by ISD Scotland on request, November 2021. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp(link is external).
  3. Northern Ireland data were provided by the Northern Ireland Cancer Registry on request, February 2022. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.
  4. Population data were published by the Office for National statistics, accessed July 2020. The data can be found here: Population estimates for the UK, England and Wales, Scotland and Northern Ireland, provisional: mid-2019.

About this data

Data is for UK, 2017-2019, ICD-10 C81.

Last reviewed:

Hodgkin lymphoma age-standardised (AS) Open a glossary item rates for females and males combined decreased by 74% in the UK between 1971-1973 and 2017-2019.[1-4] The decrease was of a similar size in females and males.

For females, Hodgkin lymphoma AS mortality rates in the UK decreased by 72% between 1971-1973 and 2017-2019. For males, Hodgkin lymphoma AS mortality rates in the UK decreased by 74% between 1971-1973 and 2017-2019.

Over the last decade in the UK (between 2007-2009 and 2017-2019), Hodgkin lymphoma AS mortality rates for females and males combined remained stable. In females AS mortality rates remained stable, and in males rates remained stable.

Hodgkin Lymphoma (C81), European Age-Standardised Mortality Rates per 100,000 Persons Population, UK, 1971-2019

For most cancer types, mortality trends largely reflect incidence and survival trends. For example, rising mortality may reflect rising incidence and stable survival, while falling mortality may reflect rising incidence and rising survival.

Hodgkin lymphoma mortality rates have decreased overall in most broad age groups in females and males combined in the UK since the early 1970s, but have remained stable in some.[1-4] Rates in 0-24s have decreased by 91%, in 25-49s have decreased by 93%, in 50-59s have decreased by 86%, in 60-69s have decreased by 79%, in 70-79s have decreased by 59% and in 80+s have remained stable.

Hodgkin Lymphoma (C81), European Age-Standardised Mortality Rates per 100,000 Persons Population, By Age, UK, 1971-2019

See also

Non-Hodgkin lymphoma mortality trends over time

Hodgkin lymphoma survival trends over time

Hodgkin lymphoma risk factors

References

  1. England and Wales data were accessed from Nomis mortality statistics by underlying cause, sex and age, November 2021: Nomis mortality statistics by underlying cause, sex and age.
  2. Scotland data were provided by ISD Scotland on request, November 2021. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp(link is external).
  3. Northern Ireland data were provided by the Northern Ireland Cancer Registry on request, February 2022. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.
  4. Population data were published by the Office for National statistics, accessed July 2020. The data can be found here: Population estimates for the UK, England and Wales, Scotland and Northern Ireland, provisional: mid-2019.

About this data

Data is for UK, 1971-2019, C81.

Cancers in children and young people (aged 0-24) are best classified using a different system to cancers in adults, so the figures presented here may not correspond with those elsewhere.

Last reviewed:

It is projected that the average number of deaths from hodgkin lymphoma in the UK every year will rise from around 330 deaths in 2023-2025 to around 360 deaths in 2038-2040.[1]

Hodgkin lymphoma mortality rates are projected to fall by 9% in the UK between 2023-2025 and 2038-2040, to less than 1 death per 100,000 people on average each year by 2038-2040.[1] This includes a similar decrease for males and females.

For females, hodgkin lymphoma European age-standardised (AS) Open a glossary item mortality rates in the UK are projected to fall by 9% between 2023-2025 and 2038-2040, to less than 1 death per 100,000 per year by 2038-2040.[1] For males, AS rates are projected to fall by 10% between 2023-2025 and 2038-2040, to 1 death per 100,000 per year by 2038-2040.[1]

Hodgkin lymphoma (C81), Observed and Projected Age-Standardised Mortality Rates, by Sex, UK, 1975-2040

Download the data table (xlsx)

See also

Find out how these projections were calculated

Mortality trends over time for Hodgkin lymphoma

Projections of mortality for all cancers combined

Download the projections data table

References

Calculated by the Cancer Intelligence Team at Cancer Research UK, February 2023. Age-period-cohort modelling approach described here, using 2020-based population projections (Office for National Statistics) and observed cancer mortality data (1975-2018).

About this data

Data is for: UK, 1979-2014 (observed), 2015-2035 (projected), ICD-10 C81

Projections are based on mortality data from 1975-2018 (England, Scotland, Wales and Northern Ireland); the above figure presents all UK data from 1975-2018 (observed) and 2019-2040 (projected). Number of deaths and age-standardised rates are presented as annual averages for each 3-year rolling period. ICD-10 codes C81.

Projections are based on observed mortality rates and therefore implicitly include changes in cancer risk factors, diagnosis and treatment. Confidence intervals are not calculated for the projected figures. Projections are by their nature uncertain because unexpected events in future could change the trend. It is not sensible to calculate a boundary of uncertainty around these already uncertain point estimates. Changes are described as 'increase' or 'decrease' if there is any difference between the point estimates.

More on projections methodology

Last reviewed:

There is evidence for an association between Hodgkin lymphoma mortality and deprivation for males in England, but there is no evidence for an association for females.[1] England-wide data for 2007-2011 show European age-standardised Open a glossary item mortality rates are 59% higher for males living in the most deprived areas compared with the least deprived, but for females the rates are similar for those living in the least and most deprived areas.[1]

Hodgkin Lymphoma (C81), European Age-Standardised Mortality Rates by Deprivation Quintile, England, 2007-2011

The estimated deprivation gradient in Hodgkin lymphoma mortality for males and females living in the most and least deprived areas in England has not changed in the period 2002-2011.[1]

It has been estimated that there would have been around 20 more cancer deaths amongst males each year in England during 2007-2011 if all males experienced the same incidence rates as the least deprived.[1] 

See also

Deprivation gradient for cancer mortality

Deprivation gradient in hodgkin lymphoma incidence

Socio-economic variation in cancer mortality for Scotland

Socio-economic variation in cancer mortality for Wales

Socio-economic variation in cancer mortality for Northern Ireland

References

  1. Cancer Research UK and National Cancer Intelligence Network. Cancer by deprivation in England: Incidence, 1996-2010, Mortality, 1997-2011. London: NCIN; 2014.

About this data

Data is for: UK, 2007-2011, ICD-10 C81

Deprivation gradient statistics were calculated using mortality data for 2007-2011. The deprivation quintiles were calculated using the Income domain scores from the Index of Multiple Deprivation (IMD) from the following years: 2004, 2007 and 2010. Full details on the data and methodology can be found in the Cancer by Deprivation in England NCIN report.

Last reviewed:

Cancer stats explained

See information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.

Cancer stats explained

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, 2 Redman Place, London, E20 1JQ or

Donate online

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.